Disclosures for "Comparative Efficacy Study on Treatment of Synaptamide (SYN) and Its Analog, Dimethylsynaptamide (DMS) in the Reduction of Murine Experimental Allergic Encephalomyelitis (EAE)"
-
Dr. Lee has nothing to disclose.
-
Mr. Calvo has nothing to disclose.
-
The institution of Amy Wang, 8982 has received research support from NIH. Amy Wang, 8982 has received personal compensation in the range of $100,000-$499,999 for serving as a scientist with NIH.
-
Mr. Kevala has received personal compensation in the range of $100,000-$499,999 for serving as a Chemist (full time employee) with National Institutes of Health.
-
Dr. Henderson has nothing to disclose.
-
Dr. Kim has nothing to disclose.
-
Dr. Marugan has nothing to disclose.
-
Dr. Fox has received personal compensation for serving as an employee of Earle A. Chiles Research Institute, Providence Health System. Dr. Fox has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Calidi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hookipa. Dr. Fox has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neogenomics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turnstone. Dr. Fox has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for UbiVac. Dr. Fox has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrimeVax. Dr. Fox has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oregon Bioscience Association. Dr. Fox has stock in Turnstone. Dr. Fox has stock in Calidi. Dr. Fox has stock in PrimeVax. Dr. Fox has stock in UbiVac. The institution of Dr. Fox has received research support from BMS. The institution of Dr. Fox has received research support from Incyte. The institution of Dr. Fox has received research support from Akoya. The institution of Dr. Fox has received research support from Macrogenics. The institution of Dr. Fox has received research support from Shimadzu. Dr. Fox has received intellectual property interests from a discovery or technology relating to health care. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Special Govt Employee - CTGTAC CBER FDA with US FDA.
-
Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.